Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
20 pending office actions • 13 art units • 19 examiners • 0 of 20 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Sun Pharmaceutical Industries, Ltd. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 2 distinct examiners, indicating that each matter is being reviewed independently by different personnel. The involvement of various art units implies that the company's legal strategy must account for different internal policies within the patent office. Practitioners should note that with this distribution, there is no overlap in examiner assignments.
HELM, CARALYNNE E is identified as the busiest examiner for this company, responsible for 1 pending office action. Because the total workload consists of only a few matters, this individual's review represents a significant portion of the company's active pipeline. Success in this sector depends on navigating the unique preferences of each assigned examiner while maintaining a cohesive narrative for the overall portfolio. The presence of 1 busiest examiner handling a portion of the work suggests a need for focused communication with that specific individual.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (5%) |
| §103 only | 9 (45%) |
| §112 only | 1 (5%) |
| Double-patenting only | 1 (5%) |
| Double-patenting + other | 3 (15%) |
| Multi-statute (no §101) | 5 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOORE, SUSANNA | 2 | 68.1% | +31.6% |
| HUTTER, GILLIAN A | 1 | 54.5% | +46.2% |
| WESTERBERG, NISSA M | 1 | 23.4% | +37.1% |
| KOSACK, JOSEPH R | 1 | 74.8% | -6.2% |
| KOSTURKO, GEORGE W | 1 | 54.7% | +49.0% |
| CHEN, PO-CHIH | 1 | 74.2% | +14.8% |
| JOHNSON, NICOLE F | 1 | 87.4% | +7.0% |
| TRUONG, QUANGLONG N | 1 | 78.8% | +23.6% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| MULLINS, JESSICA LYNN | 1 | 49.5% | +34.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18707320 | PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS | JOHNSON, NICOLE F | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18278583 | DEXAMETHASONE FOR TREATMENT OF BLEPHARITIS | KIDWELL, MICHELE M | 156d overdue |
| 19294542 | METHODS OF TREATMENT OF JAK INHIBITION RESPONSIVE CONDITIONS WITH DEUTERATED JAK INHIBITORS | HUTTER, GILLIAN A | 9d overdue |
| 19273752 | ORAL FORMULATIONS OF DEURUXOLITINIB | WESTERBERG, NISSA M | 40d |
| 18862131 | DOSAGE REGIMENS FOR TREATMENT WITH DEUTERATED JAK INHIBITORS | KOSACK, JOSEPH R | — |
| 18666084 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | CHEN, PO-CHIH | — |
| 19076661 | STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG | TCHERKASSKAYA, OLGA V | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17981237 | PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS | MULLINS, JESSICA LYNN | 51d overdue |
| 18078571 | DEUTERATED DERIVATIVES OF RUXOLITINIB | MOORE, SUSANNA | 31d overdue |
| 19294542 | METHODS OF TREATMENT OF JAK INHIBITION RESPONSIVE CONDITIONS WITH DEUTERATED JAK INHIBITORS | HUTTER, GILLIAN A | 9d overdue |
| 19273752 | ORAL FORMULATIONS OF DEURUXOLITINIB | WESTERBERG, NISSA M | 40d |
| 18905925 | DEUTERATED DERIVATIVES OF RUXOLITINIB | MOORE, SUSANNA | — |
| 18755253 | TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS | KOSTURKO, GEORGE W | — |
| 18666084 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | CHEN, PO-CHIH | — |
| 18702295 | TOPICAL COMPOSITIONS AND METHODS FOR PHOTODYNAMIC THERAPY | TRUONG, QUANGLONG N | — |
| Art Unit | Apps |
|---|---|
| 1624 | 2 |
| 1621 | 2 |
| 1615 | 2 |
| 1658 | 2 |
| 1625 | 1 |
| 1618 | 1 |
| 3796 | 1 |
| 1629 | 1 |
| 3792 | 1 |
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19294542 | METHODS OF TREATMENT OF JAK INHIBITION RESPONSIVE CONDITIONS WITH DEUTERATED JAK INHIBITORS | HUTTER, GILLIAN A | 1625 | §101§102§103DP | Final Rejection | 9d overdue | Pending | Aug 08, 2025 |
| 19273752 | ORAL FORMULATIONS OF DEURUXOLITINIB | WESTERBERG, NISSA M | 1618 | §103§112Other | Final Rejection | 40d | Pending | Jul 18, 2025 |
| 18862131 | DOSAGE REGIMENS FOR TREATMENT WITH DEUTERATED JAK INHIBITORS | KOSACK, JOSEPH R | — | §103§112Other | Non-Final OA | — | Pending | Oct 31, 2024 |
| 18905925 | DEUTERATED DERIVATIVES OF RUXOLITINIB | MOORE, SUSANNA | 1624 | §103 | Final Rejection | — | Pending | Oct 03, 2024 |
| 18755253 | TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS | KOSTURKO, GEORGE W | — | DP | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18666084 | PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS | CHEN, PO-CHIH | 1621 | §102§103Other | Non-Final OA | — | Pending | May 16, 2024 |
| 18707320 | PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS | JOHNSON, NICOLE F | 3796 | §103 | Non-Final OA | — | Pending | May 03, 2024 |
| 18702295 | TOPICAL COMPOSITIONS AND METHODS FOR PHOTODYNAMIC THERAPY | TRUONG, QUANGLONG N | 1629 | §103 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18013380 | METHODS AND INTERMEDIATES FOR PREPARING JAK INHIBITORS | O DELL, DAVID K | 1621 | §103 | Final Rejection | — | Pending | Dec 28, 2022 |
| 18078571 | DEUTERATED DERIVATIVES OF RUXOLITINIB | MOORE, SUSANNA | 1624 | §103 | Final Rejection | 31d overdue | Pending | Dec 09, 2022 |
| 17981237 | PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS | MULLINS, JESSICA LYNN | 3792 | §103 | Final Rejection | 51d overdue | Pending | Nov 04, 2022 |
| 17854066 | PHOTODYNAMIC THERAPY METHOD FOR SKIN DISORDERS | SOROUSH, LAYLA | 1622 | §103 | Non-Final OA | 56d overdue | Pending | Jun 30, 2022 |
| 19076661 | STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG | TCHERKASSKAYA, OLGA V | 1615 | §103§112 | Non-Final OA | — | Pending | Mar 11, 2025 |
| 18812726 | LONG ACTING GLP-1/GIP DUAL AGONISTS | NIEBAUER, RONALD T | 1658 | §103§112DP | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18705130 | METHOD OF INJECTING DIHYDROERGOTAMINE INTO THE BODY | ULSH, DUNG T | — | §103DP | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18278583 | DEXAMETHASONE FOR TREATMENT OF BLEPHARITIS | KIDWELL, MICHELE M | 3781 | §102§103§112 | Non-Final OA | 156d overdue | Pending | Aug 23, 2023 |
| 18264067 | OXYTOCIN READY TO INFUSE DOSAGE FORM | LEE, JIA-HAI | 1658 | §102§103§112DP | Non-Final OA | — | Pending | Aug 02, 2023 |
| 18317625 | MULTI-PARTICULATE PHARMACEUTICAL COMPOSITION OF QUETIAPINE | MERCIER, MELISSA S | 1615 | §103 | Final Rejection | 104d overdue | Pending | May 15, 2023 |
| 18158767 | METHODS FOR TREATMENT OF SUBJECTS WITH PLAQUE PSORIASIS OF THE SCALP | DONOGHUE, BRITTNEY ERIN | 1675 | §103 | Final Rejection | 88d overdue | Pending | Jan 24, 2023 |
| 17603921 | Methods for Treatment of Subjects with Psoriatic Arthritis | FORD, VANESSA L | 1674 | §112 | Non-Final OA | — | Pending | Oct 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial